Reply to C. Twelves et Al.
Dana-Farber Cancer Institute, Boston, MA.
Ann H
AH
Partridge
American Society of Clinical Oncology, Alexandria, VA.
R Bryan
RB
Rumble
Royal Marsden Hospital, London, United Kingdom.
Ian E
IE
Smith
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases
D018719:Erb-b2 Receptor Tyrosine Kinases